Injective price rebounds, but top traders stay shorting: Is $7 still possible for INJ?
Injective [INJ] posted a 13.68% recovery over the past 24 hours as buyers returned after defending a crucial support area near $4.19. The rebound lifted Injective to around $4.89 and pushed its market capitalization to $489.67 million despite a slight decline in trading volume. Trading activity reached $145.85 million, down 1.16% over the same period. Even so, the recovery encouraged traders to reassess the recent downtrend after INJ produced a strong bounce from its latest lows.